UK markets closed

BioRestorative Therapies, Inc. (BRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3801-0.0699 (-4.79%)
As of 01:21PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-15,938
-18,495
-44,303
-11,273
Depreciation & amortisation
154.816
120.545
89.108
121.384
Stock-based compensation
9,377
12,613
23,109
691.701
Change in working capital
50.866
14.144
324.685
572.35
Accounts receivable
5.7
-11
12
15
Accounts payable
-241.146
120.075
-68.024
84.631
Other working capital
-6,549
-6,311
-3,361
-1,964
Other non-cash items
160.123
-89.878
1,271
5,124
Net cash provided by operating activities
-6,230
-5,871
-3,330
-1,964
Cash flows from investing activities
Investments in property, plant and equipment
-318.6
-440.223
-30.658
-
Purchases of investments
-3,543
-13,039
0
-
Net cash used for investing activities
-171.808
-13,479
-30.658
0
Cash flows from financing activities
Debt repayment
-
-
-
0
Common stock issued
2,266
0
21,073
10
Other financing activities
-
-
-
-500
Net cash used provided by (used for) financing activities
2,266
0
21,323
5,027
Net change in cash
-4,136
-19,350
17,962
3,063
Cash at beginning of period
6,573
21,027
3,065
1.664
Cash at end of period
2,437
1,677
21,027
3,065
Free cash flow
Operating cash flow
-6,230
-5,871
-3,330
-1,964
Capital expenditure
-318.6
-440.223
-30.658
-
Free cash flow
-6,549
-6,311
-3,361
-1,964